Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schirrmann

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transferT Schirrmann, G Pecher
Biotechnology and Applied Biochemistry|December 4, 2001
Efficient cryopreservation of dendritic cells transfected with cDNA of a tumour antigen for clinical applicationG Pecher, T Schirrmann, L Kaiser, et al.
New Biotechnology|July 28, 2009
Multimerization domains for antibody phage display and antibody productionH Thie, S Binius, T Schirrmann, et al.
Current Pharmaceutical Design|August 20, 2009
Ribonucleases and immunoRNases as anticancer drugsS M Rybak, M A E Arndt, T Schirrmann, et al.
Anticancer Research|November 29, 2001
Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirusG Pecher, G Spahn, T Schirrmann, et al.
Journal of Immunological Methods|November 29, 2008
Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodiesN Strebe, A Guse, M Schüngel, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transferT Schirrmann, G Pecher
Biotechnology and Applied Biochemistry|December 4, 2001
Efficient cryopreservation of dendritic cells transfected with cDNA of a tumour antigen for clinical applicationG Pecher, T Schirrmann, L Kaiser, et al.
New Biotechnology|July 28, 2009
Multimerization domains for antibody phage display and antibody productionH Thie, S Binius, T Schirrmann, et al.
Current Pharmaceutical Design|August 20, 2009
Ribonucleases and immunoRNases as anticancer drugsS M Rybak, M A E Arndt, T Schirrmann, et al.
Anticancer Research|November 29, 2001
Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirusG Pecher, G Spahn, T Schirrmann, et al.
Journal of Immunological Methods|November 29, 2008
Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodiesN Strebe, A Guse, M Schüngel, et al.
Pageof 1